Stefan Lorenzl completed his medical studies and his doctorate studying inflammatory mechanisms of bacterial meningitis at the Ludwig Maximilians University of Munich, Munich, Germany, in 1995. After his first years as a neurologist, he joined the laboratory of Professor Beal at the Cornell University in New York, USA, as a Postdoc, in 2000. This led to the intensive investigation of extracellular matrix enzymes and their role in neurodegenerative diseases. Since that time, he has been investigating extracellular matrix enzymes as potential target for neurodegeneration and the development of inhibitors of extracellular enzymes. His clinical interest covers atypical Parkinsonian disorders with a focus on progressive supranuclear palsy and multiple system atrophy. Furthermore, he is interested in motor neuron diseases. In late 2009, he received an award for the potential role of his studies in the development of therapeutic agents for motor neuron diseases. He is currently Assistant professor at the Department of Neurology and the acting Chair of the Department of Palliative Care at the University of Munich.
Biography Updated on 14 February 2011